click below
click below
Normal Size Small Size show me how
Immunity & Inflam.
McCance, Ch. 8
Question | Answer |
---|---|
allergy | immune response to unharmful environmental antigen |
autoimmunity | immune response to own body tissue, ex, Grave's disease |
Alloimmunity | imcompatibility response to tissue of same species. transfusion rejection, ABO, fetal |
Type I | IgE; allergic reaction, require antigen crosslink, mast cell degranulation cause histamine response |
Type II | tissue (cell surface) specific reaction. IgM, IgG. Lysis, phagocytosis, ADCC, or cell malfunction. ex: ABO mismatch, Myasthenia Gravis |
Type III | immune complex mediated, hypersensitive antibodies bind to antigens in diff. tissues of body. Ex: degenerative joint dx, arthritis |
Type IV | cell-mediated,(T-lymphocyte), Tc cells or Th1 produce cytokines cause phagocytosis of tissue by lysosomal enzymes, ROS; ex: poison ivy, graft rejection, RA, TB test |
antigen | non-self substances, "foreign" to our body; i.e. virus, bacteria, etc. environmental agents |
hapten | small antigens that need carrier for immunologic response to be actived |
antibody | immunoglobulin, produced in response to challenge immune system. IgG, IgM, IgE, IgD, IgA. |
ADCC | antibody-dependent cell-mediated cytotoxicity. subpopulation of cytotoxins that are not antigen specific. (NK-natural killers, attach to Fc receptors of the IgG) |
C5-9 of complement cascade | complement mediated lysis,.damages cell membrene causing cell lysis (ex: eyrthrocyte damage during ABO mismatch, Type II) |
cryoglobulins | precipitate of immune complexes in fingers, toes, nose below body temperature, from serum sickness called Raynaud phenomenon |
Fc | receptor site on IgE |
ELISA | test that detects IgE antibodies in the serum |
contact dermatitis | Type IV allergic hypersensitivity, seen with poison ivy, metals, delayed reaction, found only at the site of contact |
atopic dermatitis | immediated Type I hypersensitivity. widely distributed lesions; hives assoc with food allergy. |
Arthus reaction | Type III. skin reaction after 1 hour exposure, peak at 6-12 hrs.skin test; SQ injection or intradermal inoculation of drug, fungal, antigen |
HLA | human leukoctye antigen; match to prevent graft rejections |
hemagglutinins | naturally occuring antibodies, IgM, assoc. with blood typing. |
universal donor | Type O |
universal recipient | Type AB |
RhD protein | antigen which determines if Rh+ or Rh-. Rh+ have RhD protein. Rhd(Rh-) can make IgG anti-D antigens if exposed to Rh+ blood. |
anti-D immunoglobulin | prevent sensitization against D antigen if given within few days of exposure to Rh+ blood |
Th1 cells, Tc cells | Th1 release cytokins that activate infiltrating macrophages and Tc cells attach endothelial cells during acute rejection (Type IV) |
hyperacute reaction | white graft, immediate and rare graft rejection, usually caused by preexisting antibodies from previous graft, bl trans. |
acute antibody-mediated rejection | Type II reaction, antibody and complement reaction , about 2 wks. sensitization, complement, neutrophils, thrombi found in graft |
chronic rejection | slow progressive failure of organ r/t inflammation to endothelial cells lining blood vessels |
opsonin | C3b factor for neutrophils |
chemotaxins | C3a, C5a for neutrophils |